共 109 条
[1]
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]
Miller KD(2015)Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases Clin Exp Metastasis 32 457-465
[3]
Jemal A(2011)Hallmarks of cancer: the next generation Cell 144 646-674
[4]
van der Geest LG(2018)Results and challenges of immune checkpoint inhibitors in colorectal cancer Expert Opin Biol Ther 18 561-573
[5]
Lam-Boer J(2017)Immune checkpoints as a target for colorectal cancer treatment Int J Mol Sci 18 1324-33
[6]
Koopman M(2016)Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting Vaccines (Basel) 4 28-30
[7]
Verhoef C(2018)Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells Immunol Cell Biol 96 21-700
[8]
Elferink MA(2015)Augmenting antitumor immune responses with epigenetic modifying agents Front Immunol 6 29-993
[9]
de Wilt JH(2013)Epigenetic changes in colorectal cancer Chin J Cancer 32 21-935
[10]
Hanahan D(2011)Epigenetics and colorectal cancer Nat Rev Gastroenterol Hepatol 8 686-236